Please ensure Javascript is enabled for purposes of website accessibility

Lilly’s Weight-Loss Pill Wins US Approval

The U.S. Food and Drug Administration on Wednesday approved Eli Lilly's weight-loss pill, making it the second to market after Novo Nordisk's oral Wegovy, as the companies fight to capture more customers with the convenience of pills over injectables. The Lilly drug, orforglipron, which will be sold under the brand...

Search

Keep the news you rely on coming. Support our work today.